Komori
Wolves Hand (194A) · InitiativeAdvanced

Expansion of the Animal Hospital Business and Strengthening of Profitability

First written in FY2025-H1. 6 of 8 entries say "Advanced", first in FY2025. Latest entry: FY2026.

8entries
2years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025-H1AdvancedFY2025 – 2026-05-13Cited as achieved2026-05-132025: 220252026: 62026
Same theme, other companies
Scaling up through animal hospital acquisitions and new openingsA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

1 other company's latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In addition to the full-year contribution from the performance of 株式会社そよかぜ and 株式会社バハティー, which joined the Group by the end of the previous consolidated fiscal year, the Group made 株式会社See a subsidiary during the current consolidated fiscal year and expanded its veterinary hospital network in the Hokkaido area.」

    In addition to the full-year contributions from そよかぜ and バハティー, the Group expanded its veterinary hospital network by making See a subsidiary. Annual consultations totaled 415,891, and the number of veterinarians reached 115.
  2. FY2026-H1AdvancedAnnual report

    「Revenue during the interim consolidated accounting period increased, driven by steady organic growth at existing hospitals and the performance of Soyokaze Co., Ltd. and Bahati Co., Ltd., which joined the group in the previous fiscal year. In addition, to accelerate our growth strategy, we made Asuka Medical Co., Ltd. of Shimogyo-ku, Kyoto, which develops, manufactures and sells therapeutic laser medical equipment, a subsidiary in October 2025, and made See Co., Ltd. of Toyohira-ku, Sapporo, which operates 1 veterinary hospital in Hokkaido, a subsidiary in November 2025.」

    In addition to organic growth at existing hospitals, acquired Asuka Medical and See, expanding the hospital business and adjacent areas.
  3. FY2025AdvancedAnnual report

    「In August 2024, we made Soyokaze Co., Ltd., which operates 3 veterinary hospitals in Saitama Prefecture, a subsidiary; in September 2024, we opened a veterinary hospital in Hachioji, Tokyo; in January 2025, we acquired the veterinary hospital business of Yasuda Animal Hospital (currently Koshien Animal Hospital) in Nishinomiya, Hyogo Prefecture; and in February 2025, we made Bahati Co., Ltd., which operates 1 veterinary hospital in Moriyama, Shiga Prefecture, a subsidiary. Along with revenue growth at existing hospitals, consolidated group revenue remained firm.」

    Executed acquisitions, new openings and business acquisitions in multiple regions, resulting in revenue of ¥5,463,817 thousand for the fiscal year ended June 2025, up 9.5% year on year.
  4. FY2025-H1First statedAnnual report

    「During the interim consolidated accounting period, with the aim of expanding the veterinary hospital business, we made Soyokaze Co., Ltd., which operates 3 veterinary hospitals in Saitama Prefecture, a subsidiary in August 2024, opened a veterinary hospital in Hachioji, Tokyo, in September 2024, and took other steps to strengthen earnings capacity.」

    Expanded the scale and earnings capacity of the hospital business through a combination of acquisitions and new openings.
Moved together

"Veterinary hospital network across Kansai, Kanto, Kyushu and Okinawa" moved the same way as this thread, in the same document, in 5 of its 8 moves.

554444★123456
  1. ★This thread
  2. 1Veterinary hospital network across Kansai, Kanto, Kyushu and Okinawa5×
  3. 2Steady revenue and profit performance5×
  4. 3Acquisition of a Healthcare and Environmental Business Utilizing Photocatalytic Technology4×
  5. 4Expanding operating areas through acquisitions and collaboration with existing hospitals4×
  6. 5Strengthening collaboration within regions and among group hospitals4×
  7. 6Drug discovery and product research leveraging the clinical platform, and the creation of new sources of revenue4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Wolves Hand yet. It last moved in the Earnings presentation of 2026-08-13: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.